Free Trial

Allergy Therapeutics (AGY) Earnings Date, Estimates & Call Transcripts

Allergy Therapeutics logo
GBX 7.70 0.00 (0.00%)
As of 01/21/2025 11:46 AM Eastern

Allergy Therapeutics Latest Earnings Summary

Latest Final
Earnings Date
Nov. 6Estimated
Actual EPS
(Nov. 6)
-GBX 1.07 Missed By -GBX 1.07

Allergy Therapeutics issued Final earnings on November 6, 2024, reporting an EPS of -GBX 1.07. With a trailing EPS of -GBX 0.06,

Get Allergy Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Allergy Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

AGY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AGY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Allergy Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate:GBX (2.56) EPS

Allergy Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/6/2024Final-GBX -1.07 -GBX 1.07---


This page (LON:AGY) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners